World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
84
Citations
32245
World Ranking
864
National Ranking
455

Craig T. Jordan publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Craig T. Jordan sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 362 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Craig T. Jordan D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Craig T. Jordan sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 84 D-Index — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Craig T. Jordan is affiliated with the University of Colorado Anschutz Medical Campus in the United States. Their research primarily focuses on Medicine, with significant contributions to Biochemistry, Genetics and Molecular Biology. Within these areas, their work extensively covers subfields such as Hematology, Molecular Biology, Immunology, Genetics, and Oncology.

The central themes of their research are centered on Acute Myeloid Leukemia (AML) and related hematologic malignancies. Key topics explored include:

  • Acute Myeloid Leukemia Research
  • Histone Deacetylase Inhibitors Research
  • Multiple Myeloma Research and Treatments
  • Protein Degradation and Inhibitors
  • Chronic Myeloid Leukemia Treatments
  • Acute Lymphoblastic Leukemia Research
  • Hematopoietic Stem Cell Transplantation

Several recent publications highlight their research contributions:

  • "Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia," 2020, Cancer Discovery
  • "Integrative analysis of drug response and clinical outcome in acute myeloid leukemia," 2022, Cancer Cell
  • "Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells," 2020, Nature Cancer
  • "Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem Cells," 2020, Cell Stem Cell
  • "Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia," 2021, Blood Advances

Craig T. Jordan frequently collaborates with a group of co-authors including Brett M. Stevens, Daniel A. Pollyea, Clayton A. Smith, Maria L. Amaya, and Jonathan A. Gutman. The number of joint publications with these colleagues ranges from 25 to over 50, indicating an ongoing collaborative research network.

Their research has been published in several recurring venues, reflecting a consistent focus on hematology and cancer biology. These venues include:

  • Blood
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Discovery
  • Haematologica
  • Cancer Research

This body of work reflects a commitment to exploring molecular and clinical aspects of blood cancers, with a particular emphasis on drug resistance mechanisms and therapeutic outcomes in acute myeloid leukemia.

Best Publications

  • Cancer Stem Cells

    Craig T. Jordan;Monica L. Guzman;Mark Noble

  • BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells.

    Eleni D. Lagadinou;Alexander Sach;Kevin Callahan;Randall M. Rossi

  • Functional genomic landscape of acute myeloid leukaemia

    Jeffrey W. Tyner;Cristina E. Tognon;Cristina E. Tognon;Daniel Bottomly;Beth Wilmot

  • The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells

    CT Jordan;D Upchurch;SJ Szilvassy;ML Guzman

  • Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells

    Monica L. Guzman;Sarah J. Neering;Sarah J. Neering;Sarah J. Neering;Donna Upchurch;Donna Upchurch;Donna Upchurch;Barry Grimes;Barry Grimes;Barry Grimes

  • The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells

    Monica L. Guzman;Randall M. Rossi;Randall M. Rossi;Lilliana Karnischky;Lilliana Karnischky;Xiaojie Li;Xiaojie Li

  • The Increasing Complexity of the Cancer Stem Cell Paradigm

    Jeffrey M. Rosen;Craig T. Jordan

  • A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations

    William Matthews;Craig T. Jordan;Gordon W. Wiegand;Drew Pardoll

  • Clonal and systemic analysis of long-term hematopoiesis in the mouse

    Craig T. Jordan;Ihor R. Lemischka

  • A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit.

    William Matthews;Craig T. Jordan;Marc Gavin;Nancy A. Jenkins

  • Preferential induction of apoptosis for primary human leukemic stem cells

    Monica L. Guzman;Carol F. Swiderski;Dianna S. Howard;Barry A. Grimes

  • Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia.

    Daniel A. Pollyea;Brett M. Stevens;Courtney L. Jones;Amanda Winters

  • Stable transduction of quiescent CD34+CD38− human hematopoietic cells by HIV-1-based lentiviral vectors

    Scott S. Case;Mary A. Price;Craig T. Jordan;Xiao Jin Yu

  • Acute myeloid leukaemia.

    Asim Khwaja;Magnus Bjorkholm;Rosemary E Gale;Ross L Levine

  • An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells

    Monica L. Guzman;Randall M. Rossi;Sundar Neelakantan;Xiaojie Li

  • PSORS2 Is Due to Mutations in CARD14

    Catherine T. Jordan;Li Cao;Elisha D.O. Roberson;Katherine C. Pierson

  • Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue Niche.

    Unknown

  • Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells.

    Courtney L. Jones;Brett M. Stevens;Angelo D'Alessandro;Julie A. Reisz

  • Leukemia Stem Cells and Microenvironment: Biology and Therapeutic Targeting

    Marina Y. Konopleva;Craig T. Jordan

  • The Molecular Basis of Leukemia

    D. Gary Gilliland;Craig T. Jordan;Carolyn A. Felix

Frequent Co-Authors

Peter A. Crooks
Peter A. Crooks University of Arkansas for Medical Sciences
Jane L. Liesveld
Jane L. Liesveld University of Rochester Medical Center
Angelo D'Alessandro
Angelo D'Alessandro University of Colorado Denver
James DeGregori
James DeGregori University of Colorado Anschutz Medical Campus
Travis Nemkov
Travis Nemkov University of Colorado Denver
Ihor R. Lemischka
Ihor R. Lemischka Icahn School of Medicine at Mount Sinai
Benjamin L. Ebert
Benjamin L. Ebert Harvard University
Scott A. Armstrong
Scott A. Armstrong Harvard University
Paul S. Brookes
Paul S. Brookes University of Rochester Medical Center
Anne M. Bowcock
Anne M. Bowcock Icahn School of Medicine at Mount Sinai

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a degree in Molecular Biology opens doors to many interdisciplinary and alternative career pathways. For those interested in supportive and community-focused roles, a human services online degree can be an excellent choice. This field emphasizes advocacy, support, and outreach — all of which can benefit from a biology background.

If you are fascinated by communication disorders and want to help others, you might consider the education required to be a speech pathologist. Understanding biology and anatomy provides a solid foundation for this rewarding profession.

Analytical skills gained in molecular biology also transfer well to other technical disciplines, such as design and engineering. Those interested in built environments may want to pursue an online architecture degree, where scientific knowledge and problem-solving abilities are always in demand.

Lastly, a strong grasp of mathematics is essential across STEM fields. Students can strengthen their background or pivot to quantitative careers with online math degrees—a flexible option that complements knowledge gained in molecular biology and expands career opportunities.

Best Scientists Citing Craig T. Jordan

Trending Scientists

Recently Published Articles